Xinqun Li
- Molecular Biology top 10%
- Oncology top 5%
- Epidemiology top 10%
- Cancer Research top 5%
- Neurology top 5%
- Topics
- Cancer, Hypoxia, and Metabolism (12 papers)Autophagy in Disease and Therapy (6 papers)Ubiquitin and proteasome pathways (4 papers)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Xinqun Li
33 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 102
- Molecular Biology 957
- Oncology 519
- Epidemiology 470
- Cancer Research 432
- Neurology 233
Countries citing papers authored by Xinqun Li
This map shows the geographic impact of Xinqun Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinqun Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinqun Li more than expected).
Fields of papers citing papers by Xinqun Li
This network shows the impact of papers produced by Xinqun Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinqun Li. The network helps show where Xinqun Li may publish in the future.
Co-authorship network of co-authors of Xinqun Li
This figure shows the co-authorship network connecting the top 25 collaborators of Xinqun Li. A scholar is included among the top collaborators of Xinqun Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinqun Li. Xinqun Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 89 | |
| 3 | 7 | |
| 4 | 22 | |
| 5 | 17 | |
| 6 | 29 | |
| 7 | 46 | |
| 8 | 54 | |
| 9 | 69 | |
| 10 | 69 | |
| 11 | 405 | |
| 12 | 6 | |
| 13 | 14 | |
| 14 | 82 | |
| 15 | Epidermal growth factor receptor (EGFR) ubiquitination as a mechanism of acquired resistance to the anti-EGFR monoclonal antibody cetuximab | 3 |
| 16 | 42 | |
| 17 | 28 | |
| 18 | 88 | |
| 19 | 100 | |
| 20 | Local expression of interleukin-12 mRNA in grafted skin in rats | 1 |
About Xinqun Li
Xinqun Li is a scholar working on Cancer Research, Oncology and Immunology and Allergy, having authored 33 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (12 papers), Autophagy in Disease and Therapy (6 papers) and Ubiquitin and proteasome pathways (4 papers). The work is most often cited by research in Geriatrics and Gerontology (193 citations), Cancer Research (432 citations) and Physiology (121 citations). Xinqun Li has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Zhen Fan, Yang Lü, Tianhong Pan, Weidong Le, Ke Liang, Joseph Jankovic, Yun‐Cheng Wu, Wenjie Xie, Joseph Jankovic and Julie Zhu. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.